Second Adjuvant Radioiodine Therapy after Reoperation for Locoregionally Persistent or Recurrent Papillary Thyroid Carcinoma

Introduction  Differentiated thyroid carcinoma (DTC) has increased incidence. Intermediate- and high-risk patients have lymph node relapse rate ranging from 10 to 50%, and receive multiple reinterventions, increasing the morbidity of the disease. Currently, there are no established guidelines for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Cadena-Piñeros, Enrique, Escobar, Judith Vásconez, Carreño, Jose A., Rojas, Julian G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665986/
https://www.ncbi.nlm.nih.gov/pubmed/36398303
http://dx.doi.org/10.1055/s-0042-1750404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665986/
https://www.ncbi.nlm.nih.gov/pubmed/36398303
http://dx.doi.org/10.1055/s-0042-1750404

Ejemplares similares